Isodiol International Inc. is the market leader in pharmaceutical grade phytochemical compounds and the industry leader in the manufacturing and development of CBD consumer products.
Isodiol is the pioneer of many firsts for the cannabis industry including commercialization of 99%+ pure, bioactive pharmaceutical grade cannabinoids, micro-encapsulations, and nanotechnology for the highest quality consumable and topical skin care products.
To find out more about Isodiol International Inc. (CSE: ISOL) (OTC: ISOLF), please " visit the company's Investor Hub".
Ubika Research/SmallCapPower has received compensation from Isodiol International Inc. to provide analyst research coverage. For full disclosure please visit here >>
To read our full disclosure, please click on the button below: